Launch of Products and Services in the USA

1 April 2014

Source BioScience plc

('Source BioScience' or 'the Group')

Source BioScience launches its products and services in the USA - facilities in Los Angeles and Atlanta

Source BioScience plc (LSE: SBS), the international laboratory services and products business, today announces the launch of its US business operating out of facilities in Los Angeles and Atlanta. The Company will hold a ribbon cutting ceremony today at its Los Angeles site to celebrate the launch.

The ceremony is being attended by Juanita Trujillo, Mayor of Santa Fe Springs, Los Angeles, Bernadette Greene, Deputy Consul-General and Harrison Shapira and Lucy Gharibian of the UK Government's Department of Trade and Industry based in Los Angeles.

The opening of the facility in Santa Fe Springs, Los Angeles will enable the healthcare, life science, biopharma and food industries in the region to access Source BioScience's state of the art products and services, including the Company's Overnight Service™ for DNA sequencing, the fastest sequencing service in the world. Customers using this service benefit from sample collection at the end of the working day and their results returned to them by 7.00 am the following morning.

Life science customers will also benefit from rapid access to the world's largest clone resource, comprising over 20 million clones, housed at Source BioScience's Atlanta facility. Both US facilities will provide pharma and biopharma stability storage services, all fully compliant with the highest regulatory standards, and the Los Angeles facility will provide Drug Enforcement Administration compliant storage.

Dr Nick Ash, CEO at Source BioScience, commented: "We are delighted to announce the launch of our products and services portfolio into the US market.

"With our world-leading sequencing capabilities, enhanced product portfolio and bio storage facilities we know we can make a significant contribution to life science research in California and across the US from our facilities in Los Angeles and Atlanta."

- Ends -

Enquiries

Source BioScience plc

Dr Nick Ash, CEO

Tel: +44 (0)115 973 9010

Email: [email protected] 

www.sourcebioscience.com

For investor and media enquiries:

Instinctif Partners (PR Agency)

Melanie Toyne-Sewell/Donia Al Saffar

Tel: +44 (0)20 7457 2020

Email: [email protected]

About Source BioScience

Source BioScience plc (LSE: SBS) is an international laboratory services and products business serving the healthcare and life science research markets. The Healthcare operations provide screening and reference laboratory diagnostic testing for cancer and other diseases in addition to complementary products for serology, diagnostics and sample storage. The LifeSciences division provides gene-based laboratory research support from conceptualisation to implementation, calling upon a wide range of innovative technology platforms and an online catalogue of biomolecular tools including cDNA clones and antibodies. The Stability and Bio Storage division provides support for drug discovery, from biomarker discovery and clinical trial services through to stability storage and sample archiving under environmentally controlled conditions. A superior quality management system, including GLP, GCP, GMP and CPA accreditations, make the services very attractive for applications in regulatory studies or in a clinical and diagnostic setting. Source BioScience has its headquarters in Nottingham, UK. For more information see www.sourcebioscience.com